Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYALURONIDASE \RITUXIMAB Cause Fall? 9 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Fall have been filed in association with HYALURONIDASE \RITUXIMAB. This represents 1.5% of all adverse event reports for HYALURONIDASE \RITUXIMAB.

9
Reports of Fall with HYALURONIDASE \RITUXIMAB
1.5%
of all HYALURONIDASE \RITUXIMAB reports
1
Deaths
1
Hospitalizations

How Dangerous Is Fall From HYALURONIDASE \RITUXIMAB?

Of the 9 reports, 1 (11.1%) resulted in death, 1 (11.1%) required hospitalization.

Is Fall Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYALURONIDASE \RITUXIMAB. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does HYALURONIDASE \RITUXIMAB Cause?

Off label use (182) Fatigue (167) Drug ineffective (163) Alopecia (148) Pain (146) Maternal exposure during pregnancy (141) Synovitis (140) Hypertension (137) Contraindicated product administered (136) General physical health deterioration (136)

What Other Drugs Cause Fall?

ADALIMUMAB (11,399) CARBIDOPA\LEVODOPA (7,132) LENALIDOMIDE (6,229) ETANERCEPT (5,839) DALFAMPRIDINE (5,554) APIXABAN (5,063) METHOTREXATE (4,250) DIMETHYL (4,208) TOFACITINIB (4,064) PREGABALIN (4,047)

Which HYALURONIDASE \RITUXIMAB Alternatives Have Lower Fall Risk?

HYALURONIDASE \RITUXIMAB vs HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB HYALURONIDASE \RITUXIMAB vs HYDRALAZINE HYALURONIDASE \RITUXIMAB vs HYDRALAZINE\ISOSORBIDE DINITRATE HYALURONIDASE \RITUXIMAB vs HYDROCHLOROTHIAZIDE HYALURONIDASE \RITUXIMAB vs HYDROCHLOROTHIAZIDE\IRBESARTAN

Related Pages

HYALURONIDASE \RITUXIMAB Full Profile All Fall Reports All Drugs Causing Fall HYALURONIDASE \RITUXIMAB Demographics